The U.S. Food and Drug Administration has delayed its decision on Eli Lilly's LLY.N experimental treatment for early Alzheimer's disease.
911 News Blogger Template is Designed Theme for Giving Enhanced look Various Features are available Which is designed in User friendly to handle by Piki Developers. Simple and elegant themes for making it more comfortable